Positive and negative regulation of the IL-27 receptor during lymphoid cell activation

Positive and negative regulation of the IL-27 receptor during lymphoid cell activation
复制标题

DOI:
10.4049/jimmunol.174.12.7684
复制
发表时间:
2005-06-15
影响因子:
4.4
通讯作者:
Hunter, CA
Hunter, CA
中科院分区:
医学2区
文献类型:
--
作者:
Villarino, AV;Larkin, J;Hunter, CA

文献摘要

被引文献

相似文献

以前的报道集中在IL-27促进初始T细胞反应的能力上,但目前的研究发现,IL-27R的配体特异性成分WSX-1在这些细胞上的表面表达水平很低,而在效应和记忆CD4(+)和CD8(+)T细胞上的表达水平最高。因此,在感染弓形虫的过程中,体内T细胞的激活与WSX-1的表达增强有关,在体外,TCR结扎可以诱导WSX-1的表达,而与启动时存在的极化(Th1/Th2)环境无关。然而,虽然这些数据证实有丝分裂刺激促进T细胞表达WSX-1,但在急性弓形虫病期间,NK细胞和NKT细胞的激活促使WSX-1水平降低。总之,这些研究表明,IL-2可以通过激活的CD4(+)T细胞抑制WSX-1的表达,这些研究表明,IL-27R的表面水平可以受到与淋巴细胞激活相关的正负信号的调节。此外,由于WSX-1在静息NK细胞、静息NKT细胞、效应T细胞、调节性T细胞和记忆T细胞上的高水平明显,目前的工作表明IL-27可以影响天然免疫和获得性免疫的多种效应细胞。
Previous reports have focused on the ability of IL-27 to promote naive T cell responses but the present study reveals that surface expression of WSX-1, the ligand-specific component of the IL-27R, is low on these cells and that highest levels are found on effector and memory CD4(+) and CD8(+) T cells. Accordingly, during infection with Toxoplasma gondii, in vivo T cell activation is associated with enhanced expression of WSX-1, and, in vitro, TCR ligation can induce expression of WSX-1 regardless of the polarizing (Th1/Th2) environment present at the time of priming. However, while these data establish that mitogenic stimulation promotes expression of WSX-1 by T cells, activation of NK cells and NKT cells prompts a reduction in WSX-1 levels during acute toxoplasmosis. Together, with the finding that IL-2 can suppress expression of WSX-1 by activated CD4(+) T cells, these studies indicate that surface levels of the IL-27R can be regulated by positive and negative signals associated with lymphoid cell activation. Additionally, since high levels of WSX-1 are evident on resting NK cells, resting NKT cells, effector T cells, regulatory T cells, and memory T cells, the current work demonstrates that IL-27 can influence multiple effector cells of innate and adaptive immunity.